Nomura Holdings
AGIO icon

Nomura Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Nomura Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,176
Closed -$310K – 1777
2026
Q1 		$310K Sell
9,176
-3,179
-26% -$90.1K ﹤0.01% 1485
2025
Q4 		$336K Buy
+12,355
New +$433K ﹤0.01% 1643
2024
Q4 		– Sell
-9,827
Closed -$437K – 2150
2024
Q3 		$437K Sell
9,827
-2,279
-19% -$104K ﹤0.01% 1277
2024
Q2 		$522K Buy
+12,106
New +$437K ﹤0.01% 1319
2022
Q2 		– Sell
-13,000
Closed -$391K – 1786
2022
Q1 		$391K Buy
+13,000
New +$397K ﹤0.01% 1379
2021
Q3 		– Sell
-4,000
Closed -$221K – 1983
2021
Q2 		$221K Buy
+4,000
New +$224K ﹤0.01% 1716
2021
Q1 		– Sell
-12,000
Closed -$522K – 1856
2020
Q4 		$522K Buy
+12,000
New +$474K ﹤0.01% 1227
2013
Q4 		– Sell
-8,388
Closed -$235K – 1975
2013
Q3 		$235K Buy
+8,388
New +$232K ﹤0.01% 1820

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Nomura Holdings's AGIO Position: Q2 2026 in Review

Nomura Holdings sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 9,176 shares — an estimated $310K sold.

Nomura Holdings first reported a position in AGIO in Q3 2013 and held it in 8 quarters. The position peaked at $522K in Q2 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Nomura Holdings reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Nomura Holdings sold 9,176 Agios Pharmaceuticals shares in Q2 2026, an estimated $310K.
  • Nomura Holdings first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 8 quarters.
  • Nomura Holdings's Agios Pharmaceuticals position peaked at $522K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.